Compare INTZ & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INTZ | MDCX |
|---|---|---|
| Founded | 1983 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | |
| Sector | Telecommunications | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.0M | 31.1M |
| IPO Year | 2020 | N/A |
| Metric | INTZ | MDCX |
|---|---|---|
| Price | $0.95 | $1.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $7.25 | ★ $23.50 |
| AVG Volume (30 Days) | 131.8K | ★ 298.8K |
| Earning Date | 02-26-2026 | 02-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,290,000.00 | N/A |
| Revenue This Year | $35.44 | N/A |
| Revenue Next Year | $23.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 33.49 | N/A |
| 52 Week Low | $0.71 | $1.07 |
| 52 Week High | $2.64 | $8.94 |
| Indicator | INTZ | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 30.24 | 28.76 |
| Support Level | $0.90 | $1.07 |
| Resistance Level | $1.35 | $1.34 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 10.44 | 21.91 |
Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.